Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling.
1994; Lippincott Williams & Wilkins; Volume: 23; Issue: 2 Linguagem: Inglês
10.1161/01.hyp.23.2.258
ISSN1524-4563
Autores Tópico(s)Cardiovascular, Neuropeptides, and Oxidative Stress Research
ResumoHomeHypertensionVol. 23, No. 2Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBTissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. C I Johnston C I JohnstonC I Johnston Department of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia. Originally published1 Feb 1994https://doi.org/10.1161/01.HYP.23.2.258Hypertension. 1994;23:258–268 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Feliciano R, Atum A, Ruiz É, Serra A, Antônio E, Manchini M, Silva J, Tucci P, Nathanson L, Morris M, Chavantes M and Silva Júnior J (2021) Photobiomodulation Therapy on Myocardial Infarction in Rats: Transcriptional and Posttranscriptional Implications to Cardiac Remodeling, Lasers in Surgery and Medicine, 10.1002/lsm.23407, 53:9, (1247-1257), Online publication date: 1-Nov-2021. Brojakowska A, Narula J, Shimony R and Bander J (2020) Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System, Journal of the American College of Cardiology, 10.1016/j.jacc.2020.04.028, 75:24, (3085-3095), Online publication date: 1-Jun-2020. Deng J, Jiang Y, Guo Y and Li H (2020)(2020) Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations?, Chinese Medical Journal, 10.1097/CM9.0000000000000996, 133:22, (2650-2652) Nishiyama A and Kobori H (2018) Independent regulation of renin–angiotensin–aldosterone system in the kidney, Clinical and Experimental Nephrology, 10.1007/s10157-018-1567-1, 22:6, (1231-1239), Online publication date: 1-Dec-2018. Bahramali E, Firouzabadi N, Rajabi M, Manafi A, Zarghami M, Mousavi S and Jamshidi J (2017) Association of renin–angiotensin–aldosterone system gene polymorphisms with left ventricular hypertrophy in patients with heart failure with preserved ejection fraction: A case–control study, Clinical and Experimental Hypertension, 10.1080/10641963.2016.1267196, 39:4, (371-376), Online publication date: 19-May-2017. Gunduz E and Sahna E (2017) Effects of At2 Receptor Agonist Novokinin on Oxidative Stress, Inflammation and Infarct Size Due to Myocardial Ischemia-Reperfusion, Journal of Biomedical Science and Engineering, 10.4236/jbise.2017.105020, 10:05, (257-272), . Bernardi S, Michelli A, Zuolo G, Candido R and Fabris B (2016) Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease, Journal of Diabetes Research, 10.1155/2016/8917578, 2016, (1-17), . Pan H, She X, Wu H, Ma J, Ren D and Lu J (2015) Long-Term Regulation of the Local Renin–Angiotensin System in the Myocardium of Spontaneously Hypertensive Rats by Feeding Bioactive Peptides Derived from Spirulina platensis , Journal of Agricultural and Food Chemistry, 10.1021/acs.jafc.5b02801, 63:35, (7765-7774), Online publication date: 9-Sep-2015. Witzel I, Jelinek H, Khalaf K, Lee S, Khandoker A and Alsafar H (2015) Identifying Common Genetic Risk Factors of Diabetic Neuropathies, Frontiers in Endocrinology, 10.3389/fendo.2015.00088, 6 Segersvärd H, Lakkisto P, Forsten H, Immonen K, Kosonen R, Palojoki E, Kankuri E, Harjula A, Laine M and Tikkanen I (2013) Effects of angiotensin II blockade on cardiomyocyte regeneration after myocardial infarction in rats, Journal of the Renin-Angiotensin-Aldosterone System, 10.1177/1470320313487567, 16:1, (92-102), Online publication date: 1-Mar-2015. Peer M, Mashavi M, Matas Z, Harpaz D and Shargorodsky M (2014) Adiponectin as an Independent Predictor of Left Ventricular Hypertrophy in Nondiabetic Patients With Hypertension, Angiology, 10.1177/0003319714523332, 66:3, (219-224), Online publication date: 1-Mar-2015. Manchini M, Serra A, Feliciano R, Santana E, Antônio E, de Tarso Camillo de Carvalho P, Montemor J, Crajoinas R, Girardi A, Tucci P, Silva J and Chen X (2014) Amelioration of Cardiac Function and Activation of Anti-Inflammatory Vasoactive Peptides Expression in the Rat Myocardium by Low Level Laser Therapy, PLoS ONE, 10.1371/journal.pone.0101270, 9:7, (e101270) Patel S, Velkoska E, Freeman M, Wai B, Lancefield T and Burrell L (2014) From gene to protein—experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension, Frontiers in Physiology, 10.3389/fphys.2014.00227, 5 vinh quốc Lương K and Nguyễn L (2013) The beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanisms, Nutrition Journal, 10.1186/1475-2891-12-89, 12:1, Online publication date: 1-Dec-2013. Inanir A, Basol N, Karakus N and Yigit S (2013) The importance of association between angiotensin-converting enzyme (ACE) Gene I/D polymorphism and diabetic peripheral neuropathy, Gene, 10.1016/j.gene.2013.07.051, 530:2, (253-256), Online publication date: 1-Nov-2013. Patel S, Velkoska E and Burrell L (2013) Emerging markers in cardiovascular disease: Where does angiotensin-converting enzyme 2 fit in?, Clinical and Experimental Pharmacology and Physiology, 10.1111/1440-1681.12069, 40:8, (551-559), Online publication date: 1-Aug-2013. Lương K and Nguyễn L (2013) The role of thiamine in HIV infection, International Journal of Infectious Diseases, 10.1016/j.ijid.2012.11.019, 17:4, (e221-e227), Online publication date: 1-Apr-2013. Phoboo S, Pinto M, Barbosa A, Sarkar D, Bhowmik P, Jha P and Shetty K (2012) Phenolic-Linked Biochemical Rationale for the Anti-Diabetic Properties of Swertia chirayita (Roxb. ex Flem.) Karst. , Phytotherapy Research, 10.1002/ptr.4714, 27:2, (227-235), Online publication date: 1-Feb-2013. Burrell L, Harrap S, Velkoska E and Patel S (2012) The ACE2 gene: its potential as a functional candidate for cardiovascular disease , Clinical Science, 10.1042/CS20120269, 124:2, (65-76), Online publication date: 1-Jan-2013. Burchill L, Velkoska E, Dean R, Griggs K, Patel S and Burrell L (2012) Combination renin–angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions, Clinical Science, 10.1042/CS20120162, 123:11, (649-658), Online publication date: 1-Dec-2012. vinh quốc Lương K and Nguyễn L (2012) The beneficial role of vitamin D in systemic lupus erythematosus (SLE), Clinical Rheumatology, 10.1007/s10067-012-2033-1, 31:10, (1423-1435), Online publication date: 1-Oct-2012. Wang Y, Wang J, Liu R, Qi H, Wen Y, Sun F and Yin C (2012) Severe acute pancreatitis is associated with upregulation of the ACE2-angiotensin-(1-7)-Mas axis and promotes increased circulating angiotensin-(1-7), Pancreatology, 10.1016/j.pan.2012.07.017, 12:5, (451-457), Online publication date: 1-Sep-2012. Stein A, Goldmeier S, Voltolini S, Setogutti E, Feldman C, Figueiredo E, Eick R, Irigoyen M and Rigatto K (2012) Renal oxygen content is increased in healthy subjects after angiotensin-converting enzyme inhibition, Clinics, 10.6061/clinics/2012(07)10, 67:7, (761-765), Online publication date: 1-Jul-2012. Tikellis C and Thomas M (2012) Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease, International Journal of Peptides, 10.1155/2012/256294, 2012, (1-8), Online publication date: 20-Mar-2012. Clarke N and Turner A (2012) Angiotensin-Converting Enzyme 2: The First Decade, International Journal of Hypertension, 10.1155/2012/307315, 2012, (1-12), . Perry J, Bergamaschi C, Campos R, Andersen M, Montano N, Casarini D and Tufik S (2011) Sympathetic and angiotensinergic responses mediated by paradoxical sleep loss in rats, Journal of the Renin-Angiotensin-Aldosterone System, 10.1177/1470320310391504, 12:3, (146-152), Online publication date: 1-Sep-2011. Kim J, Oh S, Lee J, Hong E, Yu J, Han K, Min K, Son H and Chang S (2011) The Effect of an Angiotensin Receptor Blocker on Arterial Stiffness in Type 2 Diabetes Mellitus Patients with Hypertension, Diabetes & Metabolism Journal, 10.4093/dmj.2011.35.3.236, 35:3, (236), . Tikellis C, Bernardi S and Burns W (2011) Angiotensin-converting enzyme 2 is a key modulator of the renin–angiotensin system in cardiovascular and renal disease, Current Opinion in Nephrology and Hypertension, 10.1097/MNH.0b013e328341164a, 20:1, (62-68), Online publication date: 1-Jan-2011. Vailati M, Rocha N, Matsubara L, Padovani C, Schwartz D and Matsubara B (2010) AT1-receptor mediated vascular damage in myocardium, kidneys and liver in rats, Pesquisa Veterinária Brasileira, 10.1590/S0100-736X2010000700015, 30:7, (605-611), Online publication date: 1-Jul-2010. Ocaranza M, Lavandero S, Jalil J, Moya J, Pinto M, Novoa U, Apablaza F, González L, Hernández C, Varas M, López R, Godoy I, Verdejo H and Chiong M (2010) Angiotensin-(1–9) regulates cardiac hypertrophy in vivo and in vitro, Journal of Hypertension, 10.1097/HJH.0b013e328335d291, 28:5, (1054-1064), Online publication date: 1-May-2010. Xia C, Li L, Liu H and Cong W (2009) High expression of angiotensin-converting enzyme and angiotensin-converting enzyme 2 in preservation injury after liver transplantation in rats, Hepatology Research, 10.1111/j.1872-034X.2009.00543.x, 39:11, (1118-1124), Online publication date: 1-Nov-2009. Lai Z, Lew R, Yarski M, Mu F, Andrews R and Smith A (2009) The Identification of a Calmodulin-Binding Domain within the Cytoplasmic Tail of Angiotensin-Converting Enzyme-2, Endocrinology, 10.1210/en.2008-1274, 150:5, (2376-2381), Online publication date: 1-May-2009. Pandey R, Quan W, Hong F and jie S (2009) Vaccine for hypertension: Modulating the renin–angiotensin system, International Journal of Cardiology, 10.1016/j.ijcard.2009.03.032, 134:2, (160-168), Online publication date: 1-May-2009. Lala A and McLaughlin M (2008) Do ACE inhibitors all provide the same outcomes benefits in high-risk cardiovascular patients?, Current Hypertension Reports, 10.1007/s11906-008-0053-7, 10:4, (286-292), Online publication date: 1-Aug-2008. Shapiro Y, Boaz M, Matas Z, Fux A and Shargorodsky M (2008) The association between the renin–angiotensin–aldosterone system and arterial stiffness in young healthy subjects, Clinical Endocrinology, 10.1111/j.1365-2265.2008.03176.x, 68:4, (510-512), Online publication date: 1-Apr-2008. Shargorodsky M, Hass E, Boaz M, Gavish D and Zimlichman R (2008) High dose treatment with angiotensin II receptor blocker in patients with hypertension: Differential effect of tissue protection versus blood pressure lowering, Atherosclerosis, 10.1016/j.atherosclerosis.2006.12.036, 197:1, (303-310), Online publication date: 1-Mar-2008. Carter C and Groban L (2008) Role of the renin–angiotensin system in age-related sarcopenia and diastolic dysfunction, Aging Health, 10.2217/1745509X.4.1.37, 4:1, (37-46), Online publication date: 1-Feb-2008. Kobori H, Nangaku M, Navar L and Nishiyama A (2007) The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease, Pharmacological Reviews, 10.1124/pr.59.3.3, 59:3, (251-287), Online publication date: 1-Sep-2007. Herath C, Warner F, Lubel J, Dean R, Jia Z, Lew R, Smith A, Burrell L and Angus P (2007) Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1–7) levels in experimental biliary fibrosis, Journal of Hepatology, 10.1016/j.jhep.2007.03.008, 47:3, (387-395), Online publication date: 1-Sep-2007. Herichová I, Mravec B, Stebelová K, Križanová O, Jurkovičová D, Kvetňanský R and Zeman M (2006) Rhythmic clock gene expression in heart, kidney and some brain nuclei involved in blood pressure control in hypertensive TGR(mREN-2)27 rats, Molecular and Cellular Biochemistry, 10.1007/s11010-006-9294-4, 296:1-2, (25-34), Online publication date: 15-Feb-2007. Ocaranza M, Godoy I, Jalil J, Varas M, Collantes P, Pinto M, Roman M, Ramirez C, Copaja M, Diaz-Araya G, Castro P and Lavandero S (2006) Enalapril Attenuates Downregulation of Angiotensin-Converting Enzyme 2 in the Late Phase of Ventricular Dysfunction in Myocardial Infarcted Rat, Hypertension, 48:4, (572-578), Online publication date: 1-Oct-2006. Wetmore J, Johansen K, Sen S, Hung A and Lovett D (2006) An angiotensin converting enzyme haplotype predicts survival in patients with end stage renal disease, Human Genetics, 10.1007/s00439-006-0191-4, 120:2, (201-210), Online publication date: 1-Sep-2006. López-Hernández F and López-Novoa J (2006) The lord of the ring: Mandatory role of the kidney in drug therapy of hypertension, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2005.08.002, 111:1, (53-80), Online publication date: 1-Jul-2006. Danilczyk U and Penninger J (2006) Angiotensin-Converting Enzyme II in the Heart and the Kidney, Circulation Research, 98:4, (463-471), Online publication date: 3-Mar-2006. Carter C, Onder G, Kritchevsky S and Pahor M (2005) Angiotensin-Converting Enzyme Inhibition Intervention in Elderly Persons: Effects on Body Composition and Physical Performance, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 10.1093/gerona/60.11.1437, 60:11, (1437-1446), Online publication date: 1-Nov-2005. Cruz C, Cruz L, Domingues G and Marcílio de Souza C (2005) New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia, Expert Opinion on Drug Safety, 10.1517/14740338.4.4.677, 4:4, (677-688), Online publication date: 1-Jul-2005. Burrell L, Risvanis J, Kubota E, Dean R, MacDonald P, Lu S, Tikellis C, Grant S, Lew R, Smith A, Cooper M and Johnston C (2005) Myocardial infarction increases ACE2 expression in rat and humans, European Heart Journal, 10.1093/eurheartj/ehi114, 26:4, (369-375), Online publication date: 1-Feb-2005. Thomas M and Johnston C (2011) Valsartan, Journal of Drug Evaluation, 10.3109/14791130400002415, 2:3, (67-101), Online publication date: 1-Sep-2004. Johnston C (2004) Hormones and the cardiovascular system, Trends in Endocrinology & Metabolism, 10.1016/j.tem.2004.03.010, 15:4, (137-138), Online publication date: 1-May-2004. Burrell L, Johnston C, Tikellis C and Cooper M (2004) ACE2, a new regulator of the renin–angiotensin system, Trends in Endocrinology & Metabolism, 10.1016/j.tem.2004.03.001, 15:4, (166-169), Online publication date: 1-May-2004. Mattace-Raso F, van der Cammen T, Sayed-Tabatabaei F, van Popele N, Asmar R, Schalekamp M, Hofman A, van Duijn C and Witteman J (2004) Angiotensin-converting enzyme gene polymorphism and common carotid stiffness, Atherosclerosis, 10.1016/j.atherosclerosis.2004.01.012, 174:1, (121-126), Online publication date: 1-May-2004. Hanes D, Nahar A and Weir M (2004) The tissue renin-angiotensin-aldosterone system in diabetes mellitus, Current Hypertension Reports, 10.1007/s11906-004-0083-8, 6:2, (98-105), Online publication date: 1-Apr-2004. ARAMAKI Y, UECHI M and TAKASE K (2003) Angiotensin Converting Enzyme and Chymase Activity in the Feline Heart and Serum, Journal of Veterinary Medical Science, 10.1292/jvms.65.1115, 65:10, (1115-1118), . Paizis G, Cooper M, Schembri J, Tikellis C, Burrell L and Angus P (2002) Up-regulation of components of the renin-angiotensin system in the bile duct–ligated rat liver, Gastroenterology, 10.1053/gast.2002.36561, 123:5, (1667-1676), Online publication date: 1-Nov-2002. López-Hernández F, Carrón R and Montero M (2002) Beneficial Effects of Trandolapril in Uninephrectomized Spontaneously Hypertensive Rats: Role of Cyclooxygenase Pathway, Pharmacology & Toxicology, 10.1034/j.1600-0773.2002.910208.x, 91:2, (90-96), Online publication date: 1-Aug-2002. Dell'Italia L and Husain A (2002) Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases, Current Opinion in Cardiology, 10.1097/00001573-200207000-00009, 17:4, (374-379), Online publication date: 1-Jul-2002. Wei C, Tian B, Perry G, Meng Q, Chen Y, Oparil S and Dell'Italia L (2002) Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00191.2001, 282:6, (H2254-H2258), Online publication date: 1-Jun-2002. Jugdutt B, Menon V, Kumar D and Idikio H (2002) Vascular remodeling during healing after myocardial infarction in the dog model, Journal of the American College of Cardiology, 10.1016/S0735-1097(02)01805-3, 39:9, (1538-1545), Online publication date: 1-May-2002. Hooper W, Dowling N, Wenger N, Dilley A, Ellingsen D and Evatt B (2002) Relationship of venous thromboembolism and myocardial infarction with the renin-angiotensin system in African-Americans, American Journal of Hematology, 10.1002/ajh.10078, 70:1, (1-8), Online publication date: 1-May-2002. Han H, Hoffmann S, Hu K and Ertl G (2002) Angiotensin II subtype 1 (AT 1 ) receptors contribute to ischemic contracture and regulate chemomechanical energy transduction in isolated transgenic rat (αMHC-hAT 1 )594-17 hearts , European Journal of Heart Failure, 10.1016/S1388-9842(02)00005-3, 4:2, (131-137), Online publication date: 1-Mar-2002. Wei C, Ferrario C, Brosnihan K, Farrell D, Bradley W, Jaffa A and Dell'Italia L (2002) Angiotensin Peptides Modulate Bradykinin Levels in the Interstitium of the Dog Heart in Vivo, Journal of Pharmacology and Experimental Therapeutics, 10.1124/jpet.300.1.324, 300:1, (324-329), Online publication date: 1-Jan-2002. Dell'Italia L, Rocic P and Lucchesi P (2002) Use of angiotensin-converting enzyme inhibitors in patients with diabetes and coronary artery disease, Current Problems in Cardiology, 10.1067/mcd.2002.121580, 27:1, (6-36), Online publication date: 1-Jan-2002. Nassis L, Frauman A, Ohishi M, Zhuo J, Casley D, Johnston C and Fabiani M (2001) Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia, The Journal of Pathology, 10.1002/path.999, 195:5, (571-579), Online publication date: 1-Dec-2001. Dzau V, Bernstein K, Celermajer D, Cohen J, Dahlöf B, Deanfield J, Diez J, Drexler H, Ferrari R, van Gilst W, Hansson L, Hornig B, Husain A, Johnston C, Lazar H, Lonn E, Lüscher T, Mancini J, Mimran A, Pepine C, Rabelink T, Remme W, Ruilope L, Ruzicka M, Schunkert H, Swedberg K, Unger T, Vaughan D and Weber M (2001) The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data, The American Journal of Cardiology, 10.1016/S0002-9149(01)01878-1, 88:9, (1-20), Online publication date: 1-Nov-2001. Bäcklund T, Palojoki E, Grönholm T, Eriksson A, Vuolteenaho O, Laine M and Tikkanen I (2001) Dual inhibition of angiotensin converting enzyme and neutral endopeptidase by omapatrilat in rat in vivo, Pharmacological Research, 10.1006/phrs.2001.0875, 44:5, (411-418), Online publication date: 1-Nov-2001. Miller A and Srivastava P (2001) ANGIOTENSIN RECEPTOR BLOCKERS AND ALDOSTERONE ANTAGONISTS IN CHRONIC HEART FAILURE, Cardiology Clinics, 10.1016/S0733-8651(05)70207-1, 19:2, (195-202), Online publication date: 1-May-2001. Navar L, Mitchell K, Harrison-Bernard L, Kobori H and Nishiyama A (2016) Review: Intrarenal angiotensin II levels in normal and hypertensive states, Journal of the Renin-Angiotensin-Aldosterone System, 10.1177/14703203010020013001, 2:1_suppl, (S176-S184), Online publication date: 1-Mar-2001. Ando K and Fujita T (2001) Angiotensin converting enzyme protects acetylcholine-induced relaxation from its attenuation by formyl-methionyl-leucyl-phenylalanine in rat aorta, Journal of Hypertension, 10.1097/00004872-200102000-00008, 19:2, (223-228), Online publication date: 1-Feb-2001. Alhenc‐Gelas F and Corvol P (2000) Molecular and Physiological Aspects of Angiotensin I Converting Enzyme Comprehensive Physiology, 10.1002/cphy.cp070303, (81-103), Online publication date: 1-Dec-2000. Sugano M, Tsuchida K, Sawada S and Makino N (2000) Reduction of plasma angiotensin II to normal levels by antisense oligodeoxynucleotides against liver angiotensinogen cannot completely attenuate vascular remodeling in spontaneously hypertensive rats, Journal of Hypertension, 10.1097/00004872-200018060-00010, 18:6, (725-731), Online publication date: 1-Jun-2000. Makino N, Sugano M and Taguchi S (2000) Effects of Renin—Angiotensin System Inhibition on Cardiac Hypertrophy and Fibrosis in Spontaneously Hypertensive Rats The Hypertrophied Heart, 10.1007/978-1-4615-4423-4_17, (207-216), . Straeter-Knowlen I, Dell'italia L, Dai J, Hankes G, Dillon A, Cartee R, Pohost G and Ku D (1999) ACE inhibitors in HF restore canine pulmonary endothelial function and ANG II vasoconstriction, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.1999.277.5.H1924, 277:5, (H1924-H1930), Online publication date: 1-Nov-1999. Persson K and Andersson R (1999) Nitric oxide modulates captopril-mediated angiotensin-converting enzyme inhibition in porcine iliac arteries, European Journal of Pharmacology, 10.1016/S0014-2999(99)00689-5, 385:1, (21-27), Online publication date: 1-Nov-1999. Wei C, Meng Q, Palmer R, Hageman G, Durand J, Bradley W, Farrell D, Hankes G, Oparil S and Dell'Italia L (1999) Evidence for Angiotensin-Converting Enzyme– and Chymase-Mediated Angiotensin II Formation in the Interstitial Fluid Space of the Dog Heart In Vivo, Circulation, 99:19, (2583-2589), Online publication date: 18-May-1999. López-Hernández F, Carrón R, Montero M, Flores O, López-Novoa J and Arévalo M (1999) Antihypertensive Effect of Trandolapril and Verapamil in Rats with Induced Hypertension, Journal of Cardiovascular Pharmacology, 10.1097/00005344-199905000-00011, 33:5, (748-755), Online publication date: 1-May-1999. Voors A, Pinto Y, Buikema H, Urata H, Oosterga M, Rooks G, Grandjean J, Ganten D and Van Gilst W (2009) Dual pathway for angiotensin II formation in human internal mammary arteries, British Journal of Pharmacology, 10.1038/sj.bjp.0702150, 125:5, (1028-1032), Online publication date: 1-Nov-1998. Otsuka S, Sugano M, Makino N, Sawada S, Hata T and Niho Y (1998) Interaction of mRNAs for Angiotensin II Type 1 and Type 2 Receptors to Vascular Remodeling in Spontaneously Hypertensive Rats, Hypertension, 32:3, (467-472), Online publication date: 1-Sep-1998.Tamura K, Umemura S, Sumida Y, Nyui N, Kobayashi S, Ishigami T, Kihara M, Sugaya T, Fukamizu A, Miyazaki H, Murakami K and Ishii M (1998) Effect of Genetic Deficiency of Angiotensinogen on the Renin-Angiotensin System, Hypertension, 32:2, (223-227), Online publication date: 1-Aug-1998. López-Hernández F, Flores O, López-Novoa J, Montero M and Carrón R (1998) Antihypertensive Action of Trandolapril and Verapamil in Spontaneously Hypertensive Rats After Unilateral Nephrectomy, Journal of Cardiovascular Pharmacology, 10.1097/00005344-199808000-00016, 32:2, (284-290), Online publication date: 1-Aug-1998. Shimizu M, Wang Q, Sjöquist P and Rydén L (1998) Angiotensin II Type 1 Receptor Blockade with Candesartan Protects the Porcine Myocardium from Reperfusion-Induced Injury, Journal of Cardiovascular Pharmacology, 10.1097/00005344-199808000-00010, 32:2, (231-238), Online publication date: 1-Aug-1998. Kunimoto M, Soma M and Kanmatsuse K (1998) PRODUCTION OF EICOSANOIDS AND ANGIOTENSIN II IN RESISTANCE VESSELS IN SPONTANEOUSLY HYPERTENSIVE RATS, Clinical and Experimental Pharmacology and Physiology, 10.1111/j.1440-1681.1998.tb02227.x, 25:6, (430-434), Online publication date: 1-Jun-1998. Song K, Shiota N, Takai S, Takashima H, Iwasaki H, Kim S and Miyazaki M (1998) Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed Cynomolgus monkeys, Atherosclerosis, 10.1016/S0021-9150(98)00021-5, 138:1, (171-182), Online publication date: 1-May-1998. Heller L, Opsahl J, Wernsing S, Saxena R and Katz S (1998) Myocardial and plasma renin-angiotensinogen dynamics during pressure-induced cardiac hypertrophy, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 10.1152/ajpregu.1998.274.3.R849, 274:3, (R849-R856), Online publication date: 1-Mar-1998. Weber K (1997) Extracellular Matrix Remodeling in Heart Failure , Circulation, 96:11, (4065-4082), Online publication date: 2-Dec-1997. Oka N, Asai K, Kudej R, Edwards J, Toya Y, Schwencke C, Vatner D, Vatner S and Ishikawa Y (1997) Downregulation of caveolin by chronic β-adrenergic receptor stimulation in mice, American Journal of Physiology-Cell Physiology, 10.1152/ajpcell.1997.273.6.C1957, 273:6, (C1957-C1962), Online publication date: 1-Dec-1997. Fareh J, Touyz R, Schiffrin E and Thibault G (1997) Cardiac Type-1 Angiotensin II Receptor Status in Deoxycorticosterone Acetate–Salt Hypertension in Rats, Hypertension, 30:5, (1253-1259), Online publication date: 1-Nov-1997.Kim D, Kim J, Kim S, Gwon H, Ryu J, Huh J, Choo J, Choi Y, Rhee C and Lee W (1997) Polymorphism of Angiotensin Converting Enzyme Gene Is Associated With Circulating Levels of Plasminogen Activator Inhibitor-1, Arteriosclerosis, Thrombosis, and Vascular Biology, 17:11, (3242-3247), Online publication date: 1-Nov-1997.Makino N, Sugano M, Otsuka S and Hata T (1997) Molecular Mechanism of Angiotensin II Type I and Type II Receptors in Cardiac Hypertrophy of Spontaneously Hypertensive Rats, Hypertension, 30:4, (796-802), Online publication date: 1-Oct-1997. Balcells E, Meng Q, Johnson W, Oparil S and Dell'Italia L (1997) Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.1997.273.4.H1769, 273:4, (H1769-H1774), Online publication date: 1-Oct-1997. Hibi K, Ishigami T, Kimura K, Nakao M, Iwamoto T, Tamura K, Nemoto T, Shimizu T, Mochida Y, Ochiai H, Umemura S and Ishii M (1997) Angiotensin-Converting Enzyme Gene Polymorphism Adds Risk for the Severity of Coronary Atherosclerosis in Smokers, Hypertension, 30:3, (574-579), Online publication date: 1-Sep-1997. Ohmichi N, Iwai N and Kinoshita M (1997) Expression of angiotensin converting enzyme and chymase in human atria, Journal of Hypertension, 10.1097/00004872-199715090-00003, 15:9, (935-943), Online publication date: 1-Sep-1997. Fouad-Tarazi F (1997) HYPERTENSION HEMODYNAMICS, Medical Clinics of North America, 10.1016/S0025-7125(05)70571-X, 81:5, (1131-1145), Online publication date: 1-Sep-1997. Porreca E, Di Febbo C, Mincione G, Reale M, Baccante G, Guglielmi M, Cuccurullo F and Colletta G (1997) Increased Transforming Growth Factor-β Production and Gene Expression by Peripheral Blood Monocytes of Hypertensive Patients, Hypertension, 30:1, (134-139), Online publication date: 1-Jul-1997.Tian B, Meng Q, Chen Y, Krege J, Smithies O and Oparil S (1997) Blood Pressures and Cardiovascular Homeostasis in Mice Having Reduced or Absent Angiotensin-Converting Enzyme Gene Function, Hypertension, 30:1, (128-133), Online publication date: 1-Jul-1997. Peiró C, Llergo J, Angulo J, López-Novoa J, Rodríguez-López A, Rodríguez-Mañas L and Sánchez-Ferrer C (2009) Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats, British Journal of Pharmacology, 10.1038/sj.bjp.0701261, 121:7, (1438-1444), Online publication date: 1-Jul-1997. Jandeleit-Dahm K, Burrell L, Johnston C and Koch K (1997) Elevated vascular angiotensin converting enzyme mediates increased neointima formation after balloon injury in spontaneously hypertensive rats, Journal of Hypertension, 10.1097/00004872-199715060-00011, 15:6, (643-650), Online publication date: 1-Jun-1997. Wu L, Cox A, Roe C, Dziadek M, Cooper M and Gilbert R (1997) Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system, Kidney International, 10.1038/ki.1997.214, 51:5, (1553-1567), Online publication date: 1-May-1997. Obayashi K, Horie M, Xie L, Tsuchiya K, Kubota A, Ishida H and Sasayama S (1997) Angiotensin II Inhibits Protein Kinase A–Dependent Chloride Conductance in Heart via Pertussis Toxin–Sensitive G Proteins, Circulation, 95:1, (197-204), Online publication date: 7-Jan-1997. Costerousse O, Danilov S and Alhenc-Gelas F (2009) Genetics of Angiotensin I-Converting Enzyme, Clinical and Experimental Hypertension, 10.3109/10641969709083177, 19:5-6, (659-669), Online publication date: 1-Jan-1997. Sigusch H, Vogt S, Gruber U, Reinhardt D, Lang K, Surber R, Farker K, Muller S and Hoffmann A (2009) Angiotensin-I-converting enzyme DD genotype is a risk factor of coronary artery disease , Scandinavian Journal of Clinical and Laboratory Investigation, 10.1080/00365519709056380, 57:2, (127-132), Online publication date: 1-Jan-1997. Dell'Italia L (1997) Cardiac Hypertrophy and the Renin-Angiotensin System Cardiac-Vascular Remodeling and Functional Interaction, 10.1007/978-4-431-67041-4_5, (47-66), . Nong Z, Stassen J, Moons L, Collen D and Janssens S (1996) Inhibition of Tissue Angiotensin-Converting Enzyme With Quinapril Reduces Hypoxic Pulmonary Hypertension and Pulmonary Vascular Remodeling, Circulation, 94:8, (1941-1947), Online publication date: 15-Oct-1996. Syed M, Borzak S and Jafri S (1996) Angiotensin-converting enzyme inhibition after acute myocardial infarction with special reference to the Fourth International Study of Infarct Survival (ISIS-4), Progress in Cardiovascular Diseases, 10.1016/S0033-0620(96)80026-0, 39:2, (201-206), Online publication date: 1-Sep-1996. Hosoi M, Nishizawa Y, Kogawa K, Kawagishi T, Konishi T, Maekawa K, Emoto M, Fukumoto S, Shioi A, Shoji T, Inaba M, Okuno Y and Morii H (1996) Angiotensin-Converting Enzyme Gene Polymorphism Is Associated With Carotid Arterial Wall Thickness in Non–Insulin-Dependent Diabetic Patients, Circulation, 94:4, (704-707), Online publication date: 15-Aug-1996.Iwai N, Inagami T, Ohmichi N and Kinoshita M (1996) Renin Is Expressed in Rat Macrophage/Monocyte Cells, Hypertension, 27:3, (399-403), Online publication date: 1-Mar-1996. Dell'Italia L and Oparil S (1996) Cardiac renin angiotensin system in hypertrophy and the progression to heart failure, Heart Failure Reviews, 10.1007/BF00128557, 1:1, (63-72), Online publication date: 1-Mar-1996. MACHIDA N, TAYA K, TANIYAMA H, TSUNODA N and KIRYU K (1996) Morphological Changes of Intraovarian Arteries in Horses., Journal of Equine Science, 10.1294/jes.7.59, 7:3, (59-62), . Sun Y and Weber K (1996) Angiotensin-converting enzyme and wound healing in diverse tissues of the rat, Journal of Laboratory and Clinical Medicine, 10.1016/S0022-2143(96)90170-5, 127:1, (94-101), Online publication date: 1-Jan-1996. Sun Y and Weber K (1996) Tissue angiotensin II and myocardial infarction Myocardial Ischemia: Mechanisms, Reperfusion, Protection, 10.1007/978-3-0348-8988-9_29, (479-488), . Iwai N, Shimoike H and Kinoshita M (1995) Cardiac Renin-Angiotensin System in the Hypertrophied Heart, Circulation, 92:9, (2690-2696), Online publication date: 1-Nov-1995. Meng Q, Balcells E, Dell'Italia L, Durand J and Oparil S (1995) Sensitive method for quantitation of angiotensin-converting enzyme (ACE) activity in tissue, Biochemical Pharmacology, 10.1016/0006-2952(95)02038-1, 50:9, (1445-1450), Online publication date: 1-Oct-1995. Opie L (1995) New concepts regarding events that lead to myocardial infarction, Cardiovascular Drugs and Therapy, 10.1007/BF00877858, 9:S3, (479-487), Online publication date: 1-Aug-1995. Korner P and Bobik A (1995) Cardiovascular Development After Enalapril in Spontaneously Hypertensive and Wistar-Kyoto Rats, Hypertension, 25:4, (610-619), Online publication date: 1-Apr-1995.Mattu R, Needham E, Galton D, Frangos E, Clark A and Caulfield M (1995) A DNA Variant at the Angiotensin-Converting Enzyme Gene Locus Associates With Coronary Artery Disease in the Caerphilly Heart Study, Circulation, 91:2, (270-274), Online publication date: 15-Jan-1995. Pinto Y, Buikema H and Van Gilst W (2009) Hyperactive Tissue Renin-Angiotensin Systems in Cardiovascular Dysfunction: Experimental Evidence and Clinical Hypotheses, Clinical and Experimental Hypertension, 10.3109/10641969509037418, 17:3, (441-468), Online publication date: 1-Jan-1995. Iwai N, Ohmichi N, Nakamura Y and Kinoshita M (1994) DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy., Circulation, 90:6, (2622-2628), Online publication date: 1-Dec-1994. February 1994Vol 23, Issue 2 Advertisement Article InformationMetrics Copyright © 1994 by American Heart Associationhttps://doi.org/10.1161/01.HYP.23.2.258PMID: 8307637 Originally publishedFebruary 1, 1994 PDF download Advertisement
Referência(s)